Psychiatr. praxi. 2016;17(3):104-107 | DOI: 10.36290/psy.2016.027

Aripiprazole in the treatment of bipolar disorder - its use in the clinical practice

MUDr. Sylva Racková, Ph.D.
Psychiatrická ambulance, Psychiatrie s. r. o., Plzeň
Psychiatrická klinika 1. LF UK a VFN, Praha

Aripiprazole is atypical antipsychotik (partial agonist of D2 and 5-HT1A and antagonist of 5-HT2A receptors). Aripiprazole is effective in the short and longterm treatment of bipolar affective disorder. We demonstrate on 3 case reports of bipolar patients when is possible to use aripiprazole in the treatment of this disorder.

Keywords: aripiprazole, bipolar affective disorder, efficacy, tollerability, augmentation, atypic antipsychotics

Published: October 26, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Racková S. Aripiprazole in the treatment of bipolar disorder - its use in the clinical practice. Psychiatr. praxi. 2016;17(3):104-107. doi: 10.36290/psy.2016.027.
Download citation

References

  1. European Medicines Agency, www.ema.europa.eu. Aripiprazol, poslední revize 21. 04. 2016.
  2. Meduri M, Gregoraci G, Baglivo V, Balestrieri M, Isola M, Brambilla P. A meta-analysis of efficacy and safety of aripiprazole in adult and pediatric bipolar disorder in randomized controlled trials and observational studies. J Affect Disord 2016; 191: 187-208. Go to original source... Go to PubMed...
  3. Dhillon S. Aripiprazole: a review of its use in the management of mania in adults with bipolar I disorder. Drugs. 2012; 72(1): 133-162. Go to original source... Go to PubMed...
  4. Brown R, Taylor MJ, Geddes J. Aripiprazole alone or in combination for acute mania. Cochrane Database Syst Rev. 2013; 12: CD005000. Go to original source...
  5. Fountoulakis KN, Vieta E, Schmidt F. Aripiprazole monotherapy in the treatment of bipolar disorder: a meta-analysis. J Affect Disord. 2011; 133(3): 361-170. Go to original source... Go to PubMed...
  6. Bak M, Fransen A, Janssen J, van Os J, Drukker M. Almost all antipsychotics result in weight gain: a meta-analysis. PLoS One 2014; 9(4): e94112. Go to original source... Go to PubMed...
  7. European Medicines Agency, www.ema.europa.eu. Quetiapin.
  8. Fan KY, Chen WY, Huang MC. Quetiapine-associated leucopenia and thrombocytopenia: a case report. BMC Psychiatry 2015; 7(15): 110. Go to original source...
  9. Rahman A, Mican LM, Fischer C, Campbell AH. Evaluating the incidence of leukopenia and neutropenia with valproate, quetiapine, or the combination in children and adolescents. Ann Pharmacother 2009; 43(5): 822-830. Go to original source... Go to PubMed...
  10. Park HJ, Kim JY. Incidence of Neutropenia With Valproate and Quetiapine Combination Treatment in Subjects With Acquired Brain Injuries. Arch Phys Med Rehabil 2016; 97(2): 183-188. Go to original source...
  11. Meng M, Li W, Zhang S, Wang H, Sheng J, Wang J, Li C. Using aripiprazole to reduce antipsychotic-induced hyperprolactinemia: meta-analysis of currently available randomized controlled trials. Shanghai Arch Psychiatry 2015; 27(1): 4-17.




Psychiatry for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.